Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COR-II: Naltrexone SR/Bupropion SR in Obesity
NCT00567255Phase 3Completed
- Sponsor
- Orexigen Therapeutics
- Start
- Dec 2007
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naltrexone, bupropion in obesity, Overweight, sponsored by Orexigen Therapeutics. Started Dec 2007; status: completed.
02
Drugs
naltrexonebupropion
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT00567255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00567255.